WEDNESDAY, July 2, 2025 (HealthDay News) — Attention-deficit/hyperactivity disorder (ADHD) medications remain associated with a reduced risk for various real-world outcomes, but the magnitude of these associations decreases alongside increasing prescription rates, according to a study published online June 25 in JAMA Psychiatry. Lin Li, Ph.D., from the Karolinska Institutet in Stockholm, and colleagues examined […]
The post ADHD Medications Remain Linked to Lower Risk for Real-World Adverse Outcomes first appeared on Physician’s Weekly.
